R&C Psychiatry and Integrative Medicine
9050 Pines Boulevard, Suite 150, Pembroke Pines
4.9(158 Google reviews)
United States
2 listed treatment centers serving Pembroke Pines and the surrounding area.
9050 Pines Boulevard, Suite 150, Pembroke Pines
4.9(158 Google reviews)
650 Northwest 180th Terrace, STE 101, Pembroke Pines
5.0(24 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Pembroke Pines.
3.9 miles away · Miramar
4 miles away · Davie
5595 South University Drive, Davie
3.8(56 Google reviews)
4.1 miles away · Hollywood
5.6 miles away · Hialeah
7 miles away · Hollywood
4000 Hollywood Boulevard, 715S, Hollywood
4.4(208 Google reviews)
7 miles away · Hollywood
4000 Hollywood Boulevard, 715S, Hollywood
4.7(51 Google reviews)
For people in Pembroke Pines, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and how services are billed. Both the medication and the visit for administration and observed monitoring may generate charges. Ask for an estimate that includes all components rather than the medication alone.
Prior authorization is common. Your insurer may request documentation of earlier antidepressant trials, including which medicines you tried and how you responded. Ask the treatment center who gathers these records, submits the authorization request, and follows up if the insurer needs more information. An authorization is not a guarantee that every charge will be paid.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Florida Medicaid coverage also depends on the applicable plan and requirements. The two Pembroke Pines listings in this directory currently indicate that they do not accept Medicare or Medicaid; confirm this directly before scheduling. That listing information does not establish whether your insurance benefit covers Spravato elsewhere.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Eligibility rules apply, and assistance may not cover every visit-related charge.
Before starting, ask the center and insurer:
Request the estimate and coverage explanation in writing when possible.
SPRAVATO® treatment takes place only in a REMS-certified healthcare setting. You administer the nasal spray yourself under direct observation of a healthcare provider; it is never supplied for home use. This directory lists two Pembroke Pines centers offering Spravato, but their REMS certification status is not recorded. Confirm certification with the center before arranging treatment.
For treatment-resistant depression, the typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may then occur weekly or every two weeks. Your prescriber determines your schedule; do not assume that visits will decrease on a particular date.
Plan for more than a quick appointment. Monitoring lasts at least two hours after each dose, and check-in, preparation, and any additional observation can make the total visit longer. Ask about appointment availability before requesting time off work. Consider keeping the rest of treatment day free of work or other responsibilities that require alertness.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its pickup and escort requirements before relying on a taxi or rideshare. A backup ride can help if your usual driver becomes unavailable.
If no Pembroke Pines listing is available when you search, or local centers cannot accommodate you, this directory also lists centers in Hollywood, Miami, and West Palm Beach. Confirm each center’s certification, appointment availability, insurance arrangements, and transportation requirements directly. Choose a location you can realistically reach repeatedly, not just for the first appointment.
This directory lists two Pembroke Pines centers offering SPRAVATO®, but their REMS certification status is not recorded. Ask each center to confirm that it is currently REMS-certified before scheduling a dose. Also check whether it is accepting new patients and can provide your prescribed visit schedule. If local options do not work, you can check directory listings in Hollywood, Miami, or West Palm Beach and verify the same details.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior. It is not approved for children. A prescriber must review your symptoms, previous treatments, medical history, and safety considerations to determine whether it is appropriate for you.
Coverage depends on your plan and treatment setting. Prior authorization and records of earlier antidepressant trials are common requirements. Ask about coverage for both the medicine and the monitored visit. The two Pembroke Pines directory listings indicate that they do not accept Medicare or Medicaid; verify directly. This does not mean those programs never cover Spravato. Your insurer can explain benefits and help identify participating treatment settings.
You use the nasal spray yourself while a healthcare provider directly observes you in a REMS-certified setting. Staff monitor you for at least two hours after the dose, including for sedation, dissociation, breathing problems, and blood pressure increases. Your total appointment may take longer. The medicine cannot be taken home. Arrange another driver, because you cannot drive until the next day after a restful sleep.
Discuss sedation, dissociation—feeling disconnected from yourself or your surroundings—breathing problems, and increases in blood pressure. Spravato has boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Tell your prescriber about your medical history, medicines, and any history of substance misuse so they can assess risks and explain the monitoring plan.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Its approval for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior requires use with an oral antidepressant. If you are in crisis, call or text 988. If there is immediate danger or a medical emergency, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.